Literature DB >> 23934119

Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state.

Roberto Romero1, Tinnakorn Chaiworapongsa.   

Abstract

A 24-year-old nulliparous woman developed mildly elevated blood pressure (140-150/90-100 mmHg) without proteinuria (20 mg protein in a 24-hour urine collection) at 30⁶/⁷ weeks of gestation. The fetus was small for gestational age (estimated fetal weight under the fifth percentile). At 32⁵/⁷ weeks of gestation, the patient complained of epigastric pain, blood pressure was 180/110 mmHg, proteinuria was documented (780 mg protein in a 24-hour urine collection), schistocytes were detected in the peripheral smear, platelet count was 60,000 cells per mm³, and serum glutamic oxaloacetic transaminase was 234 U/l. The patient was diagnosed with severe preeclampsia/HELLP syndrome. Antenatal steroids were administered to induce fetal lung maturity. She and her family want to know the causes of this condition, what treatment is available, and whether there are any long-term implications of this diagnosis.

Entities:  

Mesh:

Year:  2013        PMID: 23934119      PMCID: PMC3999621          DOI: 10.1172/JCI70431

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Adi Tarca; Juan Pedro Kusanovic; Pooja Mittal; Sun Kwon Kim; Francesca Gotsch; Offer Erez; Edi Vaisbuch; Shali Mazaki-Tovi; Percy Pacora; Giovanna Ogge; Zhong Dong; Chong Jai Kim; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-12

2.  Clinical significance, prevalence, and natural history of thrombocytopenia in pregnancy-induced hypertension.

Authors:  R Romero; M Mazor; C J Lockwood; M Emamian; K P Belanger; J C Hobbins; T Duffy
Journal:  Am J Perinatol       Date:  1989-01       Impact factor: 1.862

3.  Clinical significance of liver dysfunction in pregnancy-induced hypertension.

Authors:  R Romero; J Vizoso; M Emamian; T Duffy; C Riely; T Halford; E Oyarzun; F Naftolin; J C Hobbins
Journal:  Am J Perinatol       Date:  1988-04       Impact factor: 1.862

4.  Pre-eclampsia: more than pregnancy-induced hypertension.

Authors:  J M Roberts; C W Redman
Journal:  Lancet       Date:  1993-06-05       Impact factor: 79.321

5.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

6.  Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect.

Authors:  Emely Castro-Rivera; Sophia Ran; Philip Thorpe; John D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-23       Impact factor: 11.205

7.  The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.

Authors:  Tinnakorn Chaiworapongsa; Jimmy Espinoza; Francesca Gotsch; Yeon Mee Kim; Gi Jin Kim; Luis F Goncalves; Samuel Edwin; Juan Pedro Kusanovic; Offer Erez; Nandor Gabor Than; Sonia S Hassan; Roberto Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2008-01

8.  Reversal of gene dysregulation in cultured cytotrophoblasts reveals possible causes of preeclampsia.

Authors:  Yan Zhou; Matthew J Gormley; Nathan M Hunkapiller; Mirhan Kapidzic; Yana Stolyarov; Victoria Feng; Masakazu Nishida; Penelope M Drake; Katherine Bianco; Fei Wang; Michael T McMaster; Susan J Fisher
Journal:  J Clin Invest       Date:  2013-06-24       Impact factor: 14.808

Review 9.  Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.

Authors:  Lisa M Askie; Lelia Duley; David J Henderson-Smart; Lesley A Stewart
Journal:  Lancet       Date:  2007-05-26       Impact factor: 79.321

10.  Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success.

Authors:  Susan E Hiby; James J Walker; Kevin M O'shaughnessy; Christopher W G Redman; Mary Carrington; John Trowsdale; Ashley Moffett
Journal:  J Exp Med       Date:  2004-10-11       Impact factor: 14.307

View more
  33 in total

1.  The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.

Authors:  Roberto Romero; Offer Erez; Eli Maymon; Piya Chaemsaithong; Zhonghui Xu; Percy Pacora; Tinnakorn Chaiworapongsa; Bogdan Done; Sonia S Hassan; Adi L Tarca
Journal:  Am J Obstet Gynecol       Date:  2017-03-03       Impact factor: 8.661

Review 2.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

Review 3.  Analyzing Preeclampsia as the Tip of the Iceberg Represented by Women with Long-Term Cardiovascular Disease, Atherosclerosis, and Inflammation.

Authors:  Angélica Lemos Debs Diniz; Maria Marta Bini Martins Paes; Aline Debs Diniz
Journal:  Curr Atheroscler Rep       Date:  2020-02-19       Impact factor: 5.113

4.  The profiles of soluble adhesion molecules in the "great obstetrical syndromes".

Authors:  Nikolina Docheva; Roberto Romero; Piya Chaemsaithong; Adi L Tarca; Gaurav Bhatti; Percy Pacora; Bogdan Panaitescu; Noppadol Chaiyasit; Tinnakorn Chaiworapongsa; Eli Maymon; Sonia S Hassan; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2018-02-01

5.  Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.

Authors:  Steven J Korzeniewski; Roberto Romero; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Chong Jai Kim; Yeon Mee Kim; Jung-Sun Kim; Bo Hyun Yoon; Sonia S Hassan; Lami Yeo
Journal:  Am J Obstet Gynecol       Date:  2015-12-11       Impact factor: 8.661

Review 6.  Current Updates on Pre-eclampsia: Maternal and Foetal Cardiovascular Diseases Predilection, Science or Myth? : Future cardiovascular disease risks in mother and child following pre-eclampsia.

Authors:  Samson A Odukoya; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2021-03-10       Impact factor: 5.369

7.  Wnt/β-catenin signaling pathway in severe preeclampsia.

Authors:  Xiaofang Wang; Zhan Zhang; Xianxu Zeng; Jinming Wang; Linlin Zhang; Wanyu Song; Ying Shi
Journal:  J Mol Histol       Date:  2018-03-30       Impact factor: 2.611

Review 8.  Angiogenic factors in diagnosis, management, and research in preeclampsia.

Authors:  Sarosh Rana; S Ananth Karumanchi; Marshall D Lindheimer
Journal:  Hypertension       Date:  2013-10-28       Impact factor: 10.190

9.  New insights into the relationship between viral infection and pregnancy complications.

Authors:  Ja-Young Kwon; Roberto Romero; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2014-04-07       Impact factor: 3.886

Review 10.  Pre-eclampsia: pathogenesis, novel diagnostics and therapies.

Authors:  Elizabeth A Phipps; Ravi Thadhani; Thomas Benzing; S Ananth Karumanchi
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.